Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKC-zeta in murine tumor T lymphocytes.
Regulation of cell proliferation by thyroid hormone (TH) has been demonstrated, but the effect of THs and the mechanisms involved in lymphocyte activity have not been elucidated. Differential expression of PKC isoenzymes and high nitric oxide synthase (NOS) activity have been described in tumor T lymphocytes. We have analyzed the direct actions of TH on normal T lymphocytes and BW5147 T lymphoma cells in relation to PKC and NOS activities. THs increased tumor and mitogen-induced normal T lymphocyte proliferation. PKC isoenzyme-selective blockers impaired these effects in both cell types, indicating the participation of Ca2+-dependent and -independent isoenzymes in normal and tumor cells, respectively. TH actions were blunted by extra- and intracellular Ca2+ blockers only in normal T lymphocytes, whereas NOS blockers impaired TH-induced proliferation in T lymphoma cells. Incubation for 24 h with TH induced a rise in total and membrane-associated PKC activities in both cell types and led to a rapid and transient effect only in tumor cells. THs increased atypical PKC-zeta expression in BW5147 cells and classical PKC isoenzymes in mitogen-stimulated normal T cells. TH augmented NOS activity and inducible NOS protein and gene expression only in tumor cells. Blockade of PKC and the atypical PKC-zeta isoform inhibited TH-mediated stimulation of inducible NOS and cell proliferation. These results show, for the first time, that differential intracellular signals are involved in TH modulation of lymphocyte physiology and pathophysiology.
Laboratorio de Inmunofarmacología, CEFYBO-CONICET, Paraguay 2155 1121 Buenos Aires, Argentina.
María Laura
ML
Barreiro Arcos
Gabriela
G
Gorelik
Alicia
A
Klecha
Ana María
AM
Genaro
Graciela A
GA
Cremaschi
D000818:Animals; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D004789:Enzyme Activation / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects*; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D016399:Lymphoma, T-Cell / Q000201:enzymology*; D051379:Mice; D052247:Nitric Oxide Synthase Type II / Q000378:metabolism*; D011493:Protein Kinase C / Q000378:metabolism*; D013963:Thyroid Hormones / Q000008:administration & dosage*; D000099221:Protein Kinase C zeta
D052247:Nitric Oxide Synthase Type II; D011493:Protein Kinase C; D013963:Thyroid Hormones; D000099221:Protein Kinase C zeta; C496317:Nos2 protein, mouse